SAYANA susp inj 104 mg/0.65ml ser us unique

7680620740017 CH-62074 G03AC06 09.02.1.
SAYANA susp inj 104 mg/0.65ml ser us unique
SAYANA susp inj 104 mg/0.65ml ser us unique
SAYANA susp inj 104 mg/0.65ml ser us unique
1 / 3
google

Details

Product number
6207401
CPT
-
Packaging group
1
Unit
Spritze(n)
Composition
medroxyprogesteroni acetas 104 mg, natrii chloridum, macrogolum 3350, polysorbatum 80, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dodecahydricus, povidonum K 17, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, methioninum, propylis parahydroxybenzoas 0.1 mg, E 218 1.04 mg, aqua ad iniectabile ad suspensionem pro 0.65 ml corresp. natrium 2.158 mg.

Articles (1)

Sayana, Injektionssuspension (104 mg/0.65 ml)
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
104.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.1 MG Substance HBESI
(N/A)
1.04 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
2.158 MG Substance HBESI

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
62074
Drug name
Sayana, Injektionssuspension
Galenic form
SUPA
ATC Code
G03AC06
Authorization status
Z
Dispensation category
B
First authorization
05/04/2012
Authorization expiration date
30/09/2025
IT number
09.02.1.
Domain
Human medicine
Field of application
Parenterales Kontrazeptivum

Packaging details

Description (FR)
SAYANA susp inj 104 mg/0.65ml ser us unique
Description (DE)
SAYANA Inj Susp 104 mg/0.65ml Einwegspr
Market launch
05/04/2012
Market withdrawal
30/09/2025
Narcotic (BTM)
No